Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)
Clinical trial NCT03239873 · COMPLETED
Trial details
- NCT number
- NCT03239873
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2018-08-14
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.